Author Archives: William Looney
Medical Economics: New Highs for a Historic Brand
Medical Economics has been named "Media Brand of the Year" but MM&M magazie, one of sister publication Pharm Exec's main competitors.
Posted in Advertising, Biotech, E-Media, Marketing, Medical Education, Strategy, healthcare Tagged Advanstar, life sciences, Medical Economics, MM&M, primary care physicians Leave a comment
HBA 2012 Woman of the Year: Thinking Beyond the Box
The Healthcare Businesswomen’s Association (HBA) has announced that its 2012 Woman of the Year (WOTY) is Carolyn Buck Luce, global pharmaceutical sector leader at Ernst & Young. She will be honored at the HBA’s annual Woman of the Year luncheon on May 3 in New York – the 23rd recipient from an organization that has set the pace in [...]
PCORI, Priorities, and Politics
William Looney looks at the three P’s of effectiveness research: PCORI, Priorities, and Politics
If you ever wanted to know what health economists might do with a billion dollars, the Obama Administration’s Patient-Centered Outcomes Research Institute [PCORI] is about to tell all: not right down to the penny, but good enough. The congressionally funded – [...]
Calculating the Cost of R&D: Defending Tufts Research
Estimates of what it takes to deliver a compound to market are more than an academic exercise — such data has an increasingly important on-the-ground impact on industry revenues, because if you cannot justify your costs how do you expect to prevail on price?
Posted in Op-Ed, R&D, pricing Tagged Donald Light, Ken Kaitin, productivity lag, R&D, Rebecca Warbuton, Tufts Center for the Study of Drug Development 1 Comment

Can Sanofi's Expanding Predictive Modeling Technology Enhance the Productivity of R&D?